Examples of Intas in a sentence
We may share your information with our parent company Intas Pharmaceuticals Ltd (Corporate House, Nr. Sola Bridge, S.
Our customers include Fine Tech Corporation Private Limited, a Reliance group entity, Gujarat Tea Processors and Packers Limited (entity owning Wagh Bakri tea brand), Intas Pharmaceuticals Limited, Agility Logistics Private Limited, Corona Remedies Private Limited, etc.
While some members of our group and third party services providers are located in countries whose laws (according to the European Commission) do not offer the same level of protection to personal data as that granted by countries within the EEA, such as Intas Pharmaceuticals Ltd (Corporate House, Nr. Sola Bridge, S.G. Highway, Thaltej, Ahmedabad, 380 054, Gujarat, India) and Lambda Therapeutic Research, Ltd (Lambda House, Plot No. 38, Survey no.
In the previous year, pursuant to the approval of the Board of Directors at their meeting held on May 26, 2016, the Company had entered into a Business Transfer Agreement dated May 26, 2016 with Intas Pharmaceuticals Limited for sale of Biotech Business Unit, as a going concern on a slump sale basis, at a consideration of ` 2,487 lakhs.
PSP received repeat business from Torrent Pharma, Intas, Cadila Healthcare, Claris.
Table 1 ranks the major Indian exporters to Tanzania by number of products registered; as the final column shows, these include firms active in the USA (with ANDAs/DMFs filed) and others inactive.Exporters to Tanzania inactive in the US include companies such as Intas, a significant player in India’s retail formulations market (rank: 18).
Intas Pharmaceuticals LimitedChairman/Member of the Committee of the Board of Directors of the Company as on March 31, 20131.
Indian manufacturers of five or more tracer medicines found in rural outlets were Intas (7), Simrone (6), and Aurochem, Lincoln, Medopharm and Emcure (5 each); the last supplied some of the ARVs.African pharmaceutical production is historically weak.
In October 2018, Accord Healthcare and Intas Pharmaceuticals filed a petition for certiorari in the U.S. Supreme Court, which was denied in November 2018.
Interview with Action Medeor, Dusseldorf, Germany, 01.03.2007 confirmed their support for manufacturing development in Tanzania.5. The interviews in India that particularly influenced the conclusions in this paper include: Intas Pharmaceuticals, 21 August, 2006, Ahmedabad; Torrent Pharmaceuticals, 21 August, 2006, Ahmedabad; Zydus Cadila, 22 August, 2006, Ahmedabad; USV, 6 May, 2008, Mumbai; Bluecross Laboratories, 7 May, 2008, Mumbai and personal communication, 23 May, 2008.